Qiao Y, Han F, Peng X, Rombenso A, Li E
Antioxidants (Basel). 2024; 13(1).
PMID: 38247477
PMC: 10812432.
DOI: 10.3390/antiox13010052.
Paulowski L, Beckham K, Johansen M, Berneking L, Van N, Degefu Y
PNAS Nexus. 2023; 1(4):pgac130.
PMID: 36714853
PMC: 9802118.
DOI: 10.1093/pnasnexus/pgac130.
Marro F, Abad L, Blocker A, Laurent F, Josse J, Valour F
J Antimicrob Chemother. 2021; 76(12):3091-3102.
PMID: 34459881
PMC: 8598303.
DOI: 10.1093/jac/dkab301.
Gregoire N, Chauzy A, Buyck J, Rammaert B, Couet W, Marchand S
Clin Pharmacokinet. 2020; 60(3):271-281.
PMID: 33313994
DOI: 10.1007/s40262-020-00968-x.
Dick T, Shin S, Koh W, Dartois V, Gengenbacher M
Antimicrob Agents Chemother. 2019; 64(2).
PMID: 31767722
PMC: 6985736.
DOI: 10.1128/AAC.01943-19.
Repositioning rifamycins for Mycobacterium abscessus lung disease.
Ganapathy U, Dartois V, Dick T
Expert Opin Drug Discov. 2019; 14(9):867-878.
PMID: 31195849
PMC: 6663560.
DOI: 10.1080/17460441.2019.1629414.
and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus.
Le Run E, Arthur M, Mainardi J
Antimicrob Agents Chemother. 2018; 62(8).
PMID: 29866869
PMC: 6105861.
DOI: 10.1128/AAC.00623-18.
Rifabutin Is Active against Mycobacterium abscessus Complex.
Aziz D, Low J, Wu M, Gengenbacher M, Teo J, Dartois V
Antimicrob Agents Chemother. 2017; 61(6).
PMID: 28396540
PMC: 5444174.
DOI: 10.1128/AAC.00155-17.
The Interplay between Daptomycin and the Immune System.
Kelesidis T
Front Immunol. 2014; 5:52.
PMID: 24575098
PMC: 3921582.
DOI: 10.3389/fimmu.2014.00052.
Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin.
Staudinger T, Redl B, Glasgow B
Biochim Biophys Acta. 2014; 1844(4):750-8.
PMID: 24530503
PMC: 3992280.
DOI: 10.1016/j.bbapap.2014.02.001.
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
Baltch A, Ritz W, Bopp L, Michelsen P, Smith R
Antimicrob Agents Chemother. 2008; 52(5):1829-33.
PMID: 18332172
PMC: 2346650.
DOI: 10.1128/AAC.01480-07.
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Baltch A, Ritz W, Bopp L, Michelsen P, Smith R
Antimicrob Agents Chemother. 2007; 51(4):1559-62.
PMID: 17283190
PMC: 1855516.
DOI: 10.1128/AAC.00973-06.
Mixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulation.
Van Bambeke F, Saffran J, Mingeot-Leclercq M, Tulkens P
Antimicrob Agents Chemother. 2005; 49(5):1695-700.
PMID: 15855483
PMC: 1087646.
DOI: 10.1128/AAC.49.5.1695-1700.2005.
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.
Mehrotra R, De Gaudio R, Palazzo M
Intensive Care Med. 2004; 30(12):2145-56.
PMID: 15536528
DOI: 10.1007/s00134-004-2428-9.
Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.
Van Bambeke F, Carryn S, Seral C, Chanteux H, Tyteca D, Mingeot-Leclercq M
Antimicrob Agents Chemother. 2004; 48(8):2853-60.
PMID: 15273091
PMC: 478544.
DOI: 10.1128/AAC.48.8.2853-2860.2004.
Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.
Uriarte S, Molestina R, Miller R, Bernabo J, Farinati A, Eiguchi K
Antimicrob Agents Chemother. 2004; 48(7):2538-43.
PMID: 15215106
PMC: 434182.
DOI: 10.1128/AAC.48.7.2538-2543.2004.
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.
Burman W, Gallicano K, Peloquin C
Clin Pharmacokinet. 2001; 40(5):327-41.
PMID: 11432536
DOI: 10.2165/00003088-200140050-00002.
Use of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophages.
Maisetta G, Batoni G, Pardini M, Boschi A, Bottai D, Esin S
Antimicrob Agents Chemother. 2000; 45(1):356-8.
PMID: 11120998
PMC: 90293.
DOI: 10.1128/AAC.45.1.356-358.2001.
Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?.
Labro M
Clin Microbiol Rev. 2000; 13(4):615-50.
PMID: 11023961
PMC: 88953.
DOI: 10.1128/CMR.13.4.615.
Population pharmacokinetics of rifabutin in human immunodeficiency virus-infected patients.
Gatti G, Papa P, Torre D, Andreoni M, Poggio A, Bassetti M
Antimicrob Agents Chemother. 1998; 42(8):2017-23.
PMID: 9687400
PMC: 105726.
DOI: 10.1128/AAC.42.8.2017.